A Certificate of Analysis (COA) is a document issued by a quality control laboratory that confirms the identity, purity, potency, and safety of a compounded medication. In the compounding pharmacy industry, COA transparency has emerged as a critical differentiator between facilities that prioritize quality and those that cut corners.
For prescribing physicians, COA access provides confidence that the medications they prescribe meet established quality standards. A comprehensive COA should include: compound identification and batch/lot number, date of testing, testing methodology (HPLC, mass spectrometry), purity and potency results with acceptance criteria, sterility testing results (for sterile preparations), endotoxin testing results, and the name of the testing laboratory.
At Nuvexa Pharmaceuticals, we publish COAs for every batch we compound. Our dual-testing protocol — combining in-house quality control with independent third-party verification — provides an additional layer of assurance that goes beyond industry standard practices.
Nuvexa Clinical Team
PharmD
Clinical pharmacist at Nuvexa Pharmaceuticals specializing in compounded pharmaceutical preparations and quality assurance.